|
US4200750A
(en)
|
1977-01-07 |
1980-04-29 |
Westwood Pharmaceuticals Inc. |
4-Substituted imidazo [1,2-a]quinoxalines
|
|
US6069143A
(en)
|
1994-12-20 |
2000-05-30 |
Smithkline Beecham Corporation |
Fibrinogen receptor antagonists
|
|
ATE448193T1
(de)
|
2002-01-18 |
2009-11-15 |
Merck & Co Inc |
ßN-(BENZYL)AMINOALKYL CARBOXYLATE, PHOSPHINATE, PHOSPHONATE UND TETRAZOLE ALS EDG REZEPTORAGONISTENß
|
|
DE60329073D1
(de)
|
2002-01-18 |
2009-10-15 |
Merck & Co Inc |
Edg-rezeptoragonisten
|
|
EP1469863A2
(en)
|
2002-01-18 |
2004-10-27 |
Merck & Co., Inc. |
Selective s1p1/edg1 receptor agonists
|
|
JP2005531506A
(ja)
|
2002-03-01 |
2005-10-20 |
メルク エンド カムパニー インコーポレーテッド |
Ｅｄｇ受容体作動薬としてのアミノアルキルホスホネートおよび関連化合物
|
|
EP1549640A4
(en)
|
2002-06-17 |
2008-08-06 |
Merck & Co Inc |
1 - ((5-ARYL-1,2,4-OXADIAZOL-3-YL) BENZYL) AZETIDINE-3-CARBOXYLATE AND 1 - ((5-ARYL-1,2,4-OXADIAZOL-3-YL) BENZYL) PYRROLIDIN-3-CARBOXYLATE AS EDG RECEPTOR AGONISTS
|
|
CA2524867A1
(en)
*
|
2003-05-15 |
2004-12-02 |
Merck & Co., Inc. |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
|
|
EP1628967B1
(en)
|
2003-05-19 |
2014-04-09 |
Irm Llc |
Immunosuppressant compounds and compositions
|
|
WO2005032465A2
(en)
*
|
2003-10-01 |
2005-04-14 |
Merck & Co., Inc. |
3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists
|
|
US7605171B2
(en)
|
2003-12-17 |
2009-10-20 |
Merck & Co., Inc. |
(3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists
|
|
TW200538433A
(en)
|
2004-02-24 |
2005-12-01 |
Irm Llc |
Immunosuppressant compounds and compositiions
|
|
CA2583681A1
(en)
|
2004-10-22 |
2006-05-04 |
Merck & Co., Inc. |
2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor agonists
|
|
WO2006100633A1
(en)
|
2005-03-23 |
2006-09-28 |
Actelion Pharmaceuticals Ltd |
NOVEL THIOPHENE DERIVATIVES AS SPHINGOSINE-l-PHOSPHATE-1 RECEPTOR AGONISTS
|
|
WO2006115188A1
(ja)
|
2005-04-22 |
2006-11-02 |
Daiichi Sankyo Company, Limited |
ヘテロ環化合物
|
|
US20080306124A1
(en)
|
2005-06-08 |
2008-12-11 |
Rainer Albert |
Polycyclic Oxadiazoles or I Soxazoles and Their Use as Sip Receptor Ligands
|
|
CN101291908A
(zh)
|
2005-08-23 |
2008-10-22 |
Irm责任有限公司 |
免疫抑制剂化合物和组合物
|
|
WO2007088450A2
(en)
*
|
2006-02-01 |
2007-08-09 |
Pfizer Products Inc. |
Chromane antagonist of the h-3 receptor
|
|
WO2007109330A2
(en)
|
2006-03-21 |
2007-09-27 |
Epix Delaware, Inc. |
S1p receptor modulating compounds
|
|
EP2003132B1
(en)
|
2006-04-03 |
2014-03-05 |
Astellas Pharma Inc. |
Oxadiazole derivatives as S1P1 agonists
|
|
JP2009269819A
(ja)
|
2006-08-25 |
2009-11-19 |
Asahi Kasei Pharma Kk |
アミン化合物
|
|
CL2007002594A1
(es)
|
2006-09-08 |
2008-06-06 |
Actelion Pharmaceuticals Ltd |
Compuestos derivados de piridin-3-il, agentes inmunomoduladores; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de enfermedades asociadas con un sistema inmunologico activado. .
|
|
GB0625648D0
(en)
|
2006-12-21 |
2007-01-31 |
Glaxo Group Ltd |
Compounds
|
|
DK2125797T3
(da)
|
2007-03-16 |
2014-02-10 |
Actelion Pharmaceuticals Ltd |
Aminopyridinderivater som s1p1/edg1-receptoragonister
|
|
CN101970420B
(zh)
|
2007-10-04 |
2014-09-24 |
默克雪兰诺有限公司 |
噁二唑衍生物
|
|
BRPI0818804A2
(pt)
|
2007-11-01 |
2015-04-22 |
Actelion Pharmaceuticals Ltd |
Composto derivado de pirimidina, composição farmacêutica que o compreende e uso desse composto.
|
|
GB0725105D0
(en)
|
2007-12-21 |
2008-01-30 |
Glaxo Group Ltd |
Compounds
|
|
US20090298894A1
(en)
*
|
2008-04-21 |
2009-12-03 |
Asahi Kasei Pharma Corporation |
Amino acid compounds
|
|
US8741923B2
(en)
*
|
2008-12-18 |
2014-06-03 |
Merck Serono Sa |
Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis
|
|
EP2202232A1
(en)
*
|
2008-12-26 |
2010-06-30 |
Laboratorios Almirall, S.A. |
1,2,4-oxadiazole derivatives and their therapeutic use
|
|
EP2210890A1
(en)
|
2009-01-19 |
2010-07-28 |
Almirall, S.A. |
Oxadiazole derivatives as S1P1 receptor agonists
|
|
WO2010085581A1
(en)
*
|
2009-01-23 |
2010-07-29 |
Bristol-Myers Squibb Company |
Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
|
|
ES2405054T3
(es)
|
2009-01-23 |
2013-05-30 |
Bristol-Myers Squibb Company |
Derivados de pirazol-1,2,4-oxadiazol como agonistas de esfingosina-1-fosfato
|
|
EP2389377B1
(en)
|
2009-01-23 |
2014-07-16 |
Bristol-Myers Squibb Company |
Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
|
|
US8399451B2
(en)
|
2009-08-07 |
2013-03-19 |
Bristol-Myers Squibb Company |
Heterocyclic compounds
|
|
AU2010319879A1
(en)
|
2009-10-29 |
2012-06-14 |
Bristol-Myers Squibb Company |
Tricyclic heterocyclic compounds
|
|
JP5735634B2
(ja)
|
2010-04-23 |
2015-06-17 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
スフィンゴシン−１−リン酸受容体１アゴニストとしての４−（５−イソオキサゾリルまたは５−ピラゾリル−１，２，４−オキサジアゾール−３−イル）−マンデル酸アミド化合物
|
|
JP5788507B2
(ja)
|
2010-07-20 |
2015-09-30 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
置換３−フェニル−１，２，４−オキサジアゾール化合物
|
|
WO2012040532A1
(en)
|
2010-09-24 |
2012-03-29 |
Bristol-Myers Squibb Company |
Substituted oxadiazole compounds and their use as s1p1 agonists
|